Merck, a leading science and technology company, has officially opened its new M Lab™ Collaboration Centre in Molsheim, France. The centre is Merck's first in Europe and ninth worldwide, providing biopharmaceutical manufacturers with a shared, exploratory environment where they can closely collaborate with Merck scientists and engineers to solve their toughest challenges and accelerate development and production of new therapies.
Merck's newest M Lab™ Collaboration centre, which offers 4,000 square meters of space, represents a significant investment in the region. The €10 million centre provides customers in Europe, the Middle East and Africa with a fully equipped, non-GMP pilot and bench scale lab and meeting centre where they can work alongside Merck experts to solve their most pressing processing development challenges without impacting their production line.
The centre in Molsheim is the latest in Merck's network of centres around the world. Other M Lab™ Collaboration centres are located in the United States, Brazil, China, South Korea, Singapore, Japan, India (where there are two labs).
